Related references
Note: Only part of the references are listed.Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis
Michael Ahdoot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study
Michael S. Hofman et al.
LANCET (2020)
Multifocal Primary Prostate Cancer Exhibits High Degree of Genomic Heterogeneity
Marthe Lovf et al.
EUROPEAN UROLOGY (2019)
A Rich Array of Prostate Cancer Molecular Biomarkers: Opportunities and Challenges
Indu Kohaar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Controversies in MR targeted biopsy: alone or combined, cognitive versus software-based fusion, transrectal versus transperineal approach?
Giancarlo Marra et al.
WORLD JOURNAL OF UROLOGY (2019)
Magnetic resonance imaging-transrectal ultrasound fusion image-guided prostate biopsy: Current status of the cancer detection and the prospects of tailor-made medicine of the prostate cancer
Sunao Shoji
INVESTIGATIVE AND CLINICAL UROLOGY (2019)
Updated Guidelines for Metastatic Hormone-sensitive Prostate Cancer: Abiraterone Acetate Combined with Castration Is Another Standard
Nicolas Mottet et al.
EUROPEAN UROLOGY (2018)
The Diverse Genomic Landscape of Clinically Low-risk Prostate Cancer
Matthew R. Cooperberg et al.
EUROPEAN UROLOGY (2018)
Genomic Markers in Prostate Cancer Decision Making
Vito Cucchiara et al.
EUROPEAN UROLOGY (2018)
Prostate-Specific Antigen-Based Screening for Prostate Cancer Evidence Report and Systematic Review for the US Preventive Services Task Force
Joshua J. Fenton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen et al.
SCIENCE (2018)
Targeted Prostate Biopsy in the Era of Active Surveillance
Fuad F. Elkhoury et al.
UROLOGY (2018)
Molecular Biomarkers in the Clinical Management of Prostate Cancer
Aaron M. Udagerl et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Are localized prostate cancer biomarkers useful in the clinical practice?
Arie Carneiro et al.
TUMOR BIOLOGY (2018)
Improving the Specificity of PSA Screening with Serum and Urine Markers
James T. Kearns et al.
CURRENT UROLOGY REPORTS (2018)
Transcriptomic heterogeneity in multifocal prostate cancer
Simpa S. Salami et al.
JCI INSIGHT (2018)
Prognostic Biomarkers Used for Localised Prostate Cancer Management: A Systematic Review
Pierre-Jean Lamy et al.
EUROPEAN UROLOGY FOCUS (2018)
The Diagnosis and Treatment of Prostate Cancer A Review
Mark S. Litwin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomics
Hui Wang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2017)
EEG machine learning for accurate detection of cholinergic intervention and Alzheimer's disease
Sonja Simpraga et al.
SCIENTIFIC REPORTS (2017)
The role of prostate cancer biomarkers in undiagnosed men
Hasan Dani et al.
CURRENT OPINION IN UROLOGY (2017)
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma Definition of Grading Patterns and Proposal for a New Grading System
Jonathan I. Epstein et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
Molecular Profiles of Prostate Cancer: To Treat or Not to Treat
Itay A. Sternberg et al.
ANNUAL REVIEW OF MEDICINE, VOL 67 (2016)
Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer
Akash Kumar et al.
NATURE MEDICINE (2016)
Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer
Yunee Kim et al.
NATURE COMMUNICATIONS (2016)
Spatial genomic heterogeneity within localized, multifocal prostate cancer
Paul C. Boutros et al.
NATURE GENETICS (2015)
Genomic analysis in active surveillance: predicting high-risk disease using tissue biomarkers
Michael J. Donovan et al.
CURRENT OPINION IN UROLOGY (2014)
Antibody-independent targeted quantification of TMPRSS2-ERG fusion protein products in prostate cancer
Jintang He et al.
MOLECULAR ONCOLOGY (2014)
The Role of MRI in Prostate Cancer Active Surveillance
Linda M. Johnson et al.
BIOMED RESEARCH INTERNATIONAL (2014)
A Blood-Based Proteomic Classifier for the Molecular Characterization of Pulmonary Nodules
Xiao-jun Li et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay tests
Tao Liu et al.
JOURNAL OF PROTEOMICS (2012)
Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions
Paola Picotti et al.
NATURE METHODS (2012)
Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum
Tujin Shi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression
C. A. DeRosa et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2012)
Optimally splitting cases for training and testing high dimensional classifiers
Kevin K. Dobbin et al.
BMC MEDICAL GENOMICS (2011)
Skyline: an open source document editor for creating and analyzing targeted proteomics experiments
Brendan MacLean et al.
BIOINFORMATICS (2010)
ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification
B. Furusato et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2010)
Selected reaction monitoring for quantitative proteomics: a tutorial
Vinzenz Lange et al.
MOLECULAR SYSTEMS BIOLOGY (2008)
Mapping of TMPRSS2-ERG fusions in the context of multi-focal prostate cancer
Bungo Furusato et al.
MODERN PATHOLOGY (2008)
Prostate-specific membrane antigen expression as a predictor of prostate cancer progression
Sven Perner et al.
HUMAN PATHOLOGY (2007)
The University of California, San Francisco cancer of the prostate risk assessment score: A straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy
MR Cooperberg et al.
JOURNAL OF UROLOGY (2005)
Introduction to Department of Defense Center for Prostate Disease Research Multicenter National Prostate Cancer Database, and analysis of changes in the PSA-era
L Sun et al.
UROLOGIC ONCOLOGY (2001)
Share Paper
